Evidence map›Paper›PMID 40842714›Full record

ArticleBMJ public health2025

Non-medical costs incurred by critically ill patients with dengue, sepsis and tetanus within a major referral hospital in Southern Vietnam: a cost of illness study.

Trinh Manh Hung, Thanh Nguyen Nguyen, Mau Toan Le, Phuc Hau Nguyen, Thanh Phong Nguyen, Thi Hue Tai Luong, Buu Chau Le, Ba Thanh Pham, Thi Trang Khiet Tieu, Thi Diem Thuy Tran and 6 more

Abstract read
In one paragraph

Article in BMJ public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Trinh Manh HungOxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam.ORCID https://orcid.org/0000-0002-9374-5962
Thanh Nguyen NguyenHospital for Tropical Diseases, Ho Chi Minh City, Viet Nam.
Mau Toan LeHospital for Tropical Diseases, Ho Chi Minh City, Viet Nam.
Phuc Hau NguyenHospital for Tropical Diseases, Ho Chi Minh City, Viet Nam.
Thanh Phong NguyenHospital for Tropical Diseases, Ho Chi Minh City, Viet Nam.
Thi Hue Tai LuongHospital for Tropical Diseases, Ho Chi Minh City, Viet Nam.
Buu Chau LeHospital for Tropical Diseases, Ho Chi Minh City, Viet Nam.
Ba Thanh PhamHospital for Tropical Diseases, Ho Chi Minh City, Viet Nam.
Thi Trang Khiet TieuHospital for Tropical Diseases, Ho Chi Minh City, Viet Nam.
Thi Diem Thuy TranHospital for Tropical Diseases, Ho Chi Minh City, Viet Nam.
Minh Yen LamOxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam.
Sophie YacoubOxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam.
Sayem AhmedHealth Economics and Health Technology Assessment, School of Health and Wellbeing, University of Glasgow, Glasgow, UK.
Louise ThwaitesOxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam.
VITAL Consortium
Hugo C TurnerMRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, Norfolk Place, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Improving the knowledge of the costs of critical care is vital for informing health policy. However, cost data remain limited, particularly for low- and middle-income countries. The aim of this cross-sectional study is to describe the direct/indirect non-medical costs incurred by critically ill tetanus, sepsis and dengue patients and their families during their hospitalisation, using data from a major referral hospital in Vietnam. Methods: This study was conducted within the Hospital for Tropical Diseases in Ho Chi Minh City, a tertiary referral hospital specialising in infectious diseases serving Southern Vietnam. Patients who were admitted to the intensive care unit (ICU) and diagnosed with either tetanus, dengue or sepsis were enrolled between April and November 2022. In total, 94 patients (and their caregivers) were interviewed. Structured questionnaires were used to estimate the direct non-medical costs and indirect costs (costs related to productivity/time losses) incurred during their hospitalisation by the patients and their caregivers (ie, the patients' perspective). Results: Overall, the estimated median total direct/indirect non-medical costs of the sample varied between US$511 and US$814 per patient, depending on the approach used to value the indirect costs. These total costs were broadly similar among sepsis and tetanus cases, but lower for dengue cases. The estimated indirect costs were highly sensitive to the approach used to monetise productivity losses and the valuation of informal care. Conclusion: This study demonstrates that patients admitted to the ICU with a severe infection of these diseases can incur notable direct/indirect non-medical costs. These results highlight the importance of further research in this area. These findings are particularly relevant in the context of universal health coverage targets, as even with 100% coverage of medical costs, many families are still likely to suffer financial hardship.

Indexed as

Disease VectorseconomicsHealth Services Accessibility

Identifiers

PMID40842714
PMCPMC12366576

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.